HUMANE IL-23 ANTIGEN-BINDUNGSPROTEINE

European patent · EP2493925 · In force

Register entry

Publication number
EP2493925
Application number
EP10774095
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 26, 2010
Published
Sep 5, 2012
Granted
Nov 23, 2016
Protection ends at the latest
Oct 25, 2030
Next annual fee due
Oct 31, 2026
IPC classes
C07K 16/24 (2006.01)
A61K 39/395 (2006.01)
Priority
US 254982 P 26.10.2009
US 381287 P 09.09.2010
PCT application
PCT/US2010/054148 26.10.2010
PCT publication
WO2011/056600 12.05.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Nov 23, 2016

    Granted

    Published in Swissreg on 23.11.2016

Parties

Holder

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320, US

Inventor

TOWNE, Jennifer, E.

Seattle Washington 98117, US

CHENG, Janet, D.

Seattle Washington 98119, US

O'NEILL, Jason, C.

Brier Washington 98036, US

ZHANG, Yu

Shoreline Washington 98177, US

SUN, Yu

Seattle Washington 98125, US

CERNE, Heather

Seattle Washington 98115, US

PIPER, Derek, E.

Santa Clara California 95051, US

KETCHEM, Randal, R.

Snohomish Washington 98296, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.